Global Swollen Knee Treatment Market

Swollen Knee Treatment Market Size, Share, Growth Analysis, By Type(Medications (Opioids, Corticosteroids, Others), Patient-controlled Analgesia Pumps), By End User(Hospitals, Designated Clinics, Ambulatory Surgical Centers, Others), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35A2820 | Region: Global | Published Date: July, 2024
Pages: 219 | Tables: 91 | Figures: 71

Swollen Knee Treatment Market News

  • In January 2024, Exciting news emerges for patients undergoing total knee arthroplasty (TKA) as a recent clinical trial, featured in The Journal of Bone & Joint Surgery, reveals promising results associated with diosmin, a flavonoid supplement derived from citrus fruits. The trial, conducted in partnership with Wolters Kluwer and published in the Lippincott portfolio, demonstrates that treatment with diosmin leads to notable reductions in knee and leg swelling, along with improvements in certain pain-related measures. These findings offer a potential avenue for enhancing post-operative outcomes and managing discomfort in individuals undergoing TKA, providing hope for improved recovery and quality of life. 
  • In January 2023, a groundbreaking discovery emerged from collaborative research between scientists in the United States and Japan, shedding light on a novel mechanism connecting the stiffening of cartilage tissue with the suppression of a vital protein linked to longevity. This breakthrough, detailed in a recent study published on January 10th in Nature Communications, deepens our comprehension of the processes underlying joint degeneration, a primary driver of osteoarthritis. The study's authors highlight the significance of these findings in unraveling the intricate mechanisms contributing to age-related joint deterioration, offering potential avenues for innovative therapeutic interventions in the fight against osteoarthritis.
$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Swollen Knee Treatment Market size was valued at USD 2.00 billion in 2022 and is poised to grow from USD 2.09 billion in 2023 to USD 2.97 billion by 2031, growing at a CAGR of 4.5% in the forecast period (2024-2031).

The competitive environment of the Swollen Knee Treatment market is dynamic and characterized by the presence of a mix of well-established brands, emerging players, and niche producers. Innovation is a key competitive factor. Leading brands invest in research and development to introduce new flavors, packaging formats, and health-focused variations to cater to changing consumer preferences. They often set the trends in the industry.  'Pfizer Inc. (United States) ', 'Johnson & Johnson (United States) ', 'Novartis AG (Switzerland) ', 'GlaxoSmithKline plc (United Kingdom) ', 'Merck & Co., Inc. (United States) ', 'Bayer AG (Germany) ', 'Sanofi (France) ', 'Eli Lilly and Company (United States) ', 'Abbott Laboratories (United States) ', 'AstraZeneca plc (United Kingdom) ', 'Bristol-Myers Squibb Company (United States) ', 'Boehringer Ingelheim GmbH (Germany) ', 'AbbVie Inc. (United States) ', 'Amgen Inc. (United States) ', 'F. Hoffmann-La Roche AG (Switzerland) ', 'Teva Pharmaceutical Industries Ltd. (Israel) ', 'Mylan N.V. (United States) ', 'Novo Nordisk A/S (Denmark) ', 'Allergan plc (United States) ', 'Takeda Pharmaceutical Company Limited (Japan)'

The ongoing progress in medical device technology, particularly in the realm of knee-related solutions, presents significant opportunities for innovative treatment approaches aimed at addressing various orthopedic conditions. Advancements in knee braces, supports, and orthotic implants have ushered in a new era of treatment solutions characterized by enhanced patient comfort and improved outcomes. These innovative devices are designed to provide targeted support, stability, and alignment for individuals dealing with knee-related issues, ranging from injuries to chronic conditions. The continuous evolution of these medical devices contributes to the diversification of treatment options, allowing healthcare professionals to tailor interventions based on individual patient needs. 

The market is expected to be dominated by North America, primarily attributed to several key factors driving the region's prominence in this healthcare segment. The rising geriatric population in North America, coupled with a robust healthcare infrastructure, positions the region at the forefront of knee replacement treatments. The prevalence of knee-related issues tends to increase with age, making the aging demographic a significant contributor to the demand for knee replacement procedures.  

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Global Swollen Knee Treatment Market

Report ID: SQMIG35A2820

$5,300
BUY NOW GET FREE SAMPLE